← Leaderboards
Mark C. Leavitt
Synageva Biopharma Corporation
$1,556,851
Attributed
$1,556,851
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $377.6K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,556,851 · 3
By mechanism
R44$1,475,390 · 2
R43$81,461 · 1
Top collaborators
No co-investigators on record.
Most similar at Synageva Biopharma Corporation
Same institution · by research overlap
- Alex Jordan Harvey$1,714,526
- Leandro Christmann$623,937
- Stephen H Parker$91,727
Others in their field
Top investigators on “Chickens”
- Cheng-Ming Chuong · University Of Southern California$16,254,367
- David C Page · Whitehead Institute For Biomedical Res$12,930,312
- Olivier Pourquie · Stowers Institute For Medical Research$12,828,055
- Sayera Banu · International Ctr/Diarrhoeal Dis Res$12,004,580
- Marianne Bronner-Fraser · California Institute Of Technology$11,122,510
- Parker B Antin · University Of Arizona$10,392,039
Research focus
ChickensEgg /OvumBiotechnologyTransfection /Expression VectorMonoclonal AntibodyDrug Design /Synthesis /ProductionBiological ProductsBiological AvailabilityArtificial ChromosomesCellsCharacteristicsBiotherapeutic AgentChinese HamsterChinese Hamster Ovary CellAnimalsCostCommercializationCodeDepositionDoseClinical TrialsBioreactorsEgg WhiteBase
Grant awards (5)
Enhancement of the glycosylation machinery of the hen bioreactor$369,583
R44 · FY2011 · GM · contact PI
Enhancement of the glycosylation machinery of the hen bioreactor$377,553
R44 · FY2010 · GM · contact PI
Oviduct locus BACs for expression of bio-therapeutics$346,359
R44 · FY2005 · GM
Oviduct locus BACs for expression of bio-therapeutics$381,895
R44 · FY2004 · GM
Ovalbumin locus BACs for expression of biotherapeutics$81,461
R43 · FY2003 · GM